MXPA05005669A - Composiciones que contienen anticuerpos humanos para el tratamiento de infecciones por micobacterias. - Google Patents
Composiciones que contienen anticuerpos humanos para el tratamiento de infecciones por micobacterias.Info
- Publication number
- MXPA05005669A MXPA05005669A MXPA05005669A MXPA05005669A MXPA05005669A MX PA05005669 A MXPA05005669 A MX PA05005669A MX PA05005669 A MXPA05005669 A MX PA05005669A MX PA05005669 A MXPA05005669 A MX PA05005669A MX PA05005669 A MXPA05005669 A MX PA05005669A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- compositions
- relates
- mycobacterial infections
- mycobacterial
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 206010062207 Mycobacterial infection Diseases 0.000 title abstract 2
- 208000027531 mycobacterial infectious disease Diseases 0.000 title abstract 2
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 230000003248 secreting effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1289—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Mycobacteriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invencion se relaciona con el campo de la inmunologia, especificamente con el control de enfermedades infecciosas causadas por micobacterias, basados en la administracion por via de mucosas y otras vias de composiciones de anticuerpos para la profilaxis y terapeutica. Con la presente invencion se desarrollaron composiciones de anticuerpos humanos de clase IgG, IgA secretoria o mezclas de ambos con actividad especifica contra antigenos de micobacteria para la prevencion y tratamiento de infecciones causadas por este tipo de microorganismo. Dichas composiciones demostraron su capacidad de inhibir la infeccion por micobacterias "in vivo".
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20020275A CU23406A1 (es) | 2002-11-25 | 2002-11-25 | Composiciones contienendo anticuerpos humanos para el tratamiento y profiláxis de infecciones por micobacterias |
| PCT/CU2003/000015 WO2004047865A1 (es) | 2002-11-25 | 2003-11-25 | Composiciones para el tratamiento de infecciones por micobacterias |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05005669A true MXPA05005669A (es) | 2006-02-22 |
Family
ID=32331941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05005669A MXPA05005669A (es) | 2002-11-25 | 2003-11-25 | Composiciones que contienen anticuerpos humanos para el tratamiento de infecciones por micobacterias. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20060222642A1 (es) |
| EP (1) | EP1582218B1 (es) |
| CN (1) | CN100579581C (es) |
| AR (1) | AR042140A1 (es) |
| AU (1) | AU2003285261A1 (es) |
| BR (1) | BR0316558A (es) |
| CA (1) | CA2507338A1 (es) |
| CU (1) | CU23406A1 (es) |
| DE (1) | DE60324466D1 (es) |
| MX (1) | MXPA05005669A (es) |
| MY (1) | MY143402A (es) |
| RU (1) | RU2350352C2 (es) |
| WO (1) | WO2004047865A1 (es) |
| ZA (1) | ZA200504773B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005023867A1 (en) | 2003-09-08 | 2005-03-17 | Medical Research Council | Method for the treatment or prophylaxis of tuberculosis |
| PL2821415T3 (pl) | 2012-02-29 | 2021-07-05 | Otsuka Pharmaceutical Co., Ltd. | Przeciwciało przeciwko lipoarabinomannanowi i test immunologiczny do oznaczania zakażenia kwasoopornymi prątkami przy użyciu tego przeciwciała |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816563A (en) * | 1983-11-25 | 1989-03-28 | Amtron, Inc. | Process for obtaining transfer factor from colostrum, transfer factor so obtained and use thereof |
| US5258177A (en) * | 1991-12-10 | 1993-11-02 | Alpha Therapeutic Corporation | IgA preparation and process of making the same |
| US20010007660A1 (en) * | 1997-06-04 | 2001-07-12 | Aharona Glatman-Freedman | Methods of treating and protecting against tuberculosis using a monoclonal antibody selective for mycobacterium tuberculosis |
| WO1998057993A1 (en) * | 1997-06-19 | 1998-12-23 | The Regents Of The University Of California | Secretory immunoglobulin produced by single cells and methods for making and using same |
-
2002
- 2002-11-25 CU CU20020275A patent/CU23406A1/es unknown
-
2003
- 2003-11-24 MY MYPI20034528A patent/MY143402A/en unknown
- 2003-11-25 US US10/536,298 patent/US20060222642A1/en not_active Abandoned
- 2003-11-25 WO PCT/CU2003/000015 patent/WO2004047865A1/es not_active Ceased
- 2003-11-25 CA CA002507338A patent/CA2507338A1/en not_active Abandoned
- 2003-11-25 MX MXPA05005669A patent/MXPA05005669A/es active IP Right Grant
- 2003-11-25 CN CN200380109162A patent/CN100579581C/zh not_active Expired - Fee Related
- 2003-11-25 RU RU2005119995/15A patent/RU2350352C2/ru not_active IP Right Cessation
- 2003-11-25 AR ARP030104344A patent/AR042140A1/es unknown
- 2003-11-25 AU AU2003285261A patent/AU2003285261A1/en not_active Abandoned
- 2003-11-25 BR BR0316558-2A patent/BR0316558A/pt not_active IP Right Cessation
- 2003-11-25 EP EP03778232A patent/EP1582218B1/en not_active Expired - Lifetime
- 2003-11-25 DE DE60324466T patent/DE60324466D1/de not_active Expired - Lifetime
-
2005
- 2005-06-10 ZA ZA200504773A patent/ZA200504773B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2507338A1 (en) | 2004-06-10 |
| US20060222642A1 (en) | 2006-10-05 |
| AU2003285261A1 (en) | 2004-06-18 |
| BR0316558A (pt) | 2005-10-04 |
| ZA200504773B (en) | 2007-12-27 |
| AR042140A1 (es) | 2005-06-08 |
| MY143402A (en) | 2011-05-13 |
| WO2004047865A1 (es) | 2004-06-10 |
| CN1756565A (zh) | 2006-04-05 |
| CN100579581C (zh) | 2010-01-13 |
| CU23406A1 (es) | 2009-08-04 |
| EP1582218B1 (en) | 2008-10-29 |
| RU2350352C2 (ru) | 2009-03-27 |
| EP1582218A1 (en) | 2005-10-05 |
| RU2005119995A (ru) | 2006-03-20 |
| DE60324466D1 (de) | 2008-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| McNeela et al. | A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery | |
| AU2001295671A1 (en) | Pharmaceutical composition for immunisation against aids | |
| DE60229979D1 (es) | ||
| WO2003055513A3 (en) | Bacillus subtilis spores to stimulate the immune responses | |
| ATE319475T1 (de) | Microbielles wirkstoffabgabesystem | |
| TW200640486A (en) | Composition | |
| WO2005049074A3 (en) | Methods for modulating the th2 immuneresponse to an antigen by adding or removing activated carbonyl groups from the antigen | |
| AU5162201A (en) | Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and qs-21 | |
| Verhoef et al. | Immune response in human pathology: infections caused by bacteria, viruses, fungi, and parasites | |
| ATE458496T1 (de) | Hiv-vakzine und anwendungsverfahren | |
| EE200100366A (et) | Antikehade kasutamine vähivastase farmatseutilisekompositsiooni valmistamiseks | |
| WO2002034287A3 (en) | Therapeutic vaccine formulations containing chitosan | |
| WO2004026260A3 (en) | Prophylactic and therapeutic hiv aptamers | |
| Berstad et al. | Induction of antigen-specific T cell responses in human volunteers after intranasal immunization with a whole-cell pertussis vaccine | |
| WO2005084306A3 (en) | Immunogenic compositions for chlamydia pneunomiae | |
| MY146106A (en) | Antiallergic vaccine composition, method for its preparation and use in the treatment of allergic diseases | |
| MXPA05005669A (es) | Composiciones que contienen anticuerpos humanos para el tratamiento de infecciones por micobacterias. | |
| WO2001049319A8 (de) | Zusammensetzung, enthaltend bakterielle antigene, zum vorbeugen und behandeln von allergischen erkrankungen | |
| Chung et al. | Albert Léon Charles Calmette (1863-1933) and the antituberculous BCG vaccination | |
| WO2004112832A3 (en) | Immunogenic compositions comprising multiple gonococcal antigens | |
| Kelly et al. | Rapid generation of an anthrax immunotherapeutic from goats using a novel non-toxic muramyl dipeptide adjuvant | |
| WO2001058483A3 (en) | METHODS FOR THE PREVENTION AND TREATMENT OF INFECTIONS USING ANTI-C3b(i) ANTIBODIES | |
| WO2005097179A3 (fr) | Antigene tat stabilise et ses applications pour la vaccination anti-vih. | |
| WO2002030458A8 (en) | Yersinia adhesion protein as vaccine adjuvant | |
| WO2001058486A3 (de) | Immunmodulatorisch wirksame zusammensetzungen, verfahren zu ihrer herstellung und ihre verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |